JPH07503252A - 置換アザスペラン化合物投与によるｈｉｖ誘発エイズ遅延方法 - Google Patents

置換アザスペラン化合物投与によるｈｉｖ誘発エイズ遅延方法

Info

Publication number
JPH07503252A
JPH07503252A JP5513407A JP51340793A JPH07503252A JP H07503252 A JPH07503252 A JP H07503252A JP 5513407 A JP5513407 A JP 5513407A JP 51340793 A JP51340793 A JP 51340793A JP H07503252 A JPH07503252 A JP H07503252A
Authority
JP
Japan
Prior art keywords
compound
carbon atoms
formula
composition
straight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP5513407A
Other languages
English (en)
Japanese (ja)
Inventor
バッジャー，アリソン・メアリー
Original Assignee
スミスクライン・ビーチャム・コーポレイション
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by スミスクライン・ビーチャム・コーポレイション filed Critical スミスクライン・ビーチャム・コーポレイション
Publication of JPH07503252A publication Critical patent/JPH07503252A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
JP5513407A 1992-01-28 1993-01-27 置換アザスペラン化合物投与によるｈｉｖ誘発エイズ遅延方法 Pending JPH07503252A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9201803.5 1992-01-28
GB929201803A GB9201803D0 (en) 1992-01-28 1992-01-28 Methods
PCT/US1993/000730 WO1993014760A2 (fr) 1992-01-28 1993-01-27 Procedes

Publications (1)

Publication Number Publication Date
JPH07503252A true JPH07503252A (ja) 1995-04-06

Family

ID=10709398

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5513407A Pending JPH07503252A (ja) 1992-01-28 1993-01-27 置換アザスペラン化合物投与によるｈｉｖ誘発エイズ遅延方法

Country Status (7)

Country Link
EP (1) EP0624089A4 (fr)
JP (1) JPH07503252A (fr)
KR (1) KR950700068A (fr)
AU (1) AU666175B2 (fr)
CA (1) CA2128535A1 (fr)
GB (1) GB9201803D0 (fr)
WO (1) WO1993014760A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007537251A (ja) * 2004-05-12 2007-12-20 ブリストル−マイヤーズ　スクイブ　カンパニー Ｈｉｖインテグラーゼ阻害剤：環状ピリミジノン化合物

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9315351D0 (en) * 1993-07-23 1993-09-08 Smithkline Beecham Corp Methods
GB9315340D0 (en) * 1993-07-23 1993-09-08 Smithkline Beecham Corp Methods
GB9315306D0 (en) * 1993-07-23 1993-09-08 Smithkline Beecham Corp Methods

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US181704A (en) * 1876-08-29 Improvement in flour-dressing machines
US4963557A (en) * 1987-09-28 1990-10-16 Smithkline Beecham Corporation Immunomodulatory azaspiranes
JPH06501468A (ja) * 1990-09-24 1994-02-17 スミスクライン・ビーチャム・コーポレイション 方法
ZA921120B (en) * 1991-02-19 1993-01-27 Smithkline Beecham Corp Cytokine inhibitors

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007537251A (ja) * 2004-05-12 2007-12-20 ブリストル−マイヤーズ　スクイブ　カンパニー Ｈｉｖインテグラーゼ阻害剤：環状ピリミジノン化合物

Also Published As

Publication number Publication date
EP0624089A1 (fr) 1994-11-17
KR950700068A (ko) 1995-01-16
WO1993014760A2 (fr) 1993-08-05
AU3595193A (en) 1993-09-01
CA2128535A1 (fr) 1993-08-05
AU666175B2 (en) 1996-02-01
WO1993014760A3 (fr) 1993-09-02
GB9201803D0 (en) 1992-03-11
EP0624089A4 (en) 1994-12-14

Similar Documents

Publication Publication Date Title
JP3133345B2 (ja) Ｈｉｖに対して活性な連結環状ポリアミン
JP2904827B2 (ja) 不安および不安抑うつ障害の処置に有用な医薬組成物の調製へのトリフルオロメチルフェニルテトラヒドロピリジンの使用
JP2000517323A (ja) Ｂ型肝炎およびレトロウイルス関連疾患の治療のためのジカフェオイルキナ酸の新規使用および新規カフェオイルキナ酸誘導体
AU614515B2 (en) A pharmaceutical combination for the prophylaxis and therapy of malaria
JPS63310819A (ja) 抗レトロウイルス活性をもつ糖タンパク処理抑制剤
IL96618A (en) Pharmaceutical preparations containing a history of fluoroquinolones for the treatment of pneumocystosis
JPH07503252A (ja) 置換アザスペラン化合物投与によるｈｉｖ誘発エイズ遅延方法
JPH0521891B2 (fr)
JP2013517262A (ja) 抗エイズ剤としての多環式化合物の医薬的使用
WO1995003041A1 (fr) Procede d'inhibition de la production de virus de l'immunodeficience chez l'homme au moyen d'azaspiranes substitues
US5482959A (en) Method for delaying aids in an HIV infected individual by administration of substituted azaspirane compounds
PT605700E (pt) Composicao farmacutica a base de flavopereirina e sua utilizacao no tratamento contra o virus hiv
WO1995003042A1 (fr) Procede d'inhibition de la replication des virus de l'immunodeficience humaine a l'aide d'azaspirannes substitues
JPH09500646A (ja) アザスピランによるｈｉｖの治療法
WO1992016200A1 (fr) Utilisation de derives d'acide hydroxamique pour l'inhibition de la replication virale
JPH04108731A (ja) 抗エイズウイルス剤
JPH09500647A (ja) 置換アザスピランによるヒト免疫不全ウイルス産生の阻害法
CZ367598A3 (cs) Použití substituovaného azaspiranu
AU684384B2 (en) Method of treating opportunistic infections with azaspiranes
KR20210109982A (ko) 5-(2-아마노에틸)-디벤조[cd,f]-인돌-4(5H)-온 유도체 화합물, 이의 제조방법 및 이를 유효성분으로 포함하는 항 HIV-1용 약학적 조성물
WO2011046901A2 (fr) Antiviral à large spectre et procédés d'utilisation
KR19980702833A (ko) 인간 헤르페스-바이러스-8을 치료하기 위한 펜시클로비르의 용도
JPH07188032A (ja) インフルエンザ治療薬
JPH04230322A (ja) 抗マラリア医薬組成物
MXPA98009596A (en) Use of azaspiran substituted in the treatment of a